Literature DB >> 30225831

Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations.

Mohammed Aboukaoud1, Shoshana Israel2, Chaim Brautbar2, Sara Eyal3.   

Abstract

Genetic variation can affect drug pharmacokinetics and pharmacodynamics and contribute to variability between individuals in response to medications. Specifically, differences in allele frequencies among individuals and ethnic groups have been associated with variation in their propensity to develop drug hypersensitivity reactions (HSRs). This article reviews the current knowledge on the genetic background of HSRs and its relevance to Jewish and Arab populations. The focus is on human leukocyte antigen (HLA) alleles and haplotypes as predictive markers of HSRs ("immunopharmacogenetics"), but other genes and alleles are described as well. Also discussed is the translation of the pharmacogenetic information to practice recommendations.

Entities:  

Keywords:  Arab; Jewish; human leukocyte antigens; hypersensitivity reactions

Mesh:

Substances:

Year:  2018        PMID: 30225831     DOI: 10.1007/s11095-018-2472-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  134 in total

1.  Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

Authors:  B Rzany; M Mockenhaupt; S Baur; W Schröder; U Stocker; J Mueller; N Holländer; R Bruppacher; E Schöpf
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

2.  HLA polymorphism in Israel. 9. An overall comparative analysis.

Authors:  B Bonné-Tamir; J G Bodmer; W F Bodmer; P Pickbourne; C Brautbar; E Gazit; S Nevo; R Zamir
Journal:  Tissue Antigens       Date:  1978-03

3.  Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.

Authors:  Pär Hallberg; Niclas Eriksson; Luisa Ibañez; Emmanuelle Bondon-Guitton; Reinhold Kreutz; Alfonso Carvajal; M Isabel Lucena; Esther Sancho Ponce; Mariam Molokhia; Javier Martin; Tomas Axelsson; Qun-Ying Yue; Patrik K E Magnusson; Mia Wadelius
Journal:  Lancet Diabetes Endocrinol       Date:  2016-05-03       Impact factor: 32.069

4.  Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Zhi-Sheng Liu; Chien-Hsiun Chen; Mo-Song Hsih; Rosaline Chung-yee Hui; Chia-Yu Chu; Yuan-Tsong Chen
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

5.  Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Authors:  Seth Hetherington; Arlene R Hughes; Michael Mosteller; Denise Shortino; Katherine L Baker; William Spreen; Eric Lai; Kirstie Davies; Abigail Handley; David J Dow; Mary E Fling; Michael Stocum; Clive Bowman; Linda M Thurmond; Allen D Roses
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

6.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

7.  PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Authors:  Julia M Barbarino; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2015-04       Impact factor: 2.089

8.  Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population.

Authors:  Daniel F Carr; Mas Chaponda; Andrea L Jorgensen; Elena Cornejo Castro; Joep J van Oosterhout; Saye H Khoo; David G Lalloo; Robert S Heyderman; Ana Alfirevic; Munir Pirmohamed
Journal:  Clin Infect Dis       Date:  2013-01-29       Impact factor: 9.079

9.  Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.

Authors:  Paola Nicoletti; Guruprasad P Aithal; Einar S Bjornsson; Raul J Andrade; Ashley Sawle; Marco Arrese; Huiman X Barnhart; Emmanuelle Bondon-Guitton; Paul H Hayashi; Fernando Bessone; Alfonso Carvajal; Ingolf Cascorbi; Elizabeth T Cirulli; Naga Chalasani; Anita Conforti; Sally A Coulthard; Mark J Daly; Christopher P Day; John F Dillon; Robert J Fontana; Jane I Grove; Pär Hallberg; Nelia Hernández; Luisa Ibáñez; Gerd A Kullak-Ublick; Tarja Laitinen; Dominique Larrey; M Isabel Lucena; Anke H Maitland-van der Zee; Jennifer H Martin; Mariam Molokhia; Munir Pirmohamed; Elizabeth E Powell; Shengying Qin; Jose Serrano; Camilla Stephens; Andrew Stolz; Mia Wadelius; Paul B Watkins; Aris Floratos; Yufeng Shen; Matthew R Nelson; Thomas J Urban; Ann K Daly
Journal:  Gastroenterology       Date:  2016-12-30       Impact factor: 22.682

10.  Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study.

Authors:  Pei-Lung Chen; Shyang-Rong Shih; Pei-Wen Wang; Ying-Chao Lin; Chen-Chung Chu; Jung-Hsin Lin; Szu-Chi Chen; Ching-Chung Chang; Tien-Shang Huang; Keh Sung Tsai; Fen-Yu Tseng; Chih-Yuan Wang; Jin-Ying Lu; Wei-Yih Chiu; Chien-Ching Chang; Yu-Hsuan Chen; Yuan-Tsong Chen; Cathy Shen-Jang Fann; Wei-Shiung Yang; Tien-Chun Chang
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

View more
  2 in total

Review 1.  Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Lola Corzo; Natalia Cacabelos; Juan C Carril
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

2.  Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention.

Authors:  Wajdy Al Awaida; Ali A Ahmed; Asia Ali Hamza; Khalid I Amber; Hamzeh J Al-Ameer; Yazun Jarrar; Ghizal Fatima; Ahmed O Maslat; Yulia Gushchina; Omar Al Bawareed; Najah R Hadi
Journal:  Heliyon       Date:  2021-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.